| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-30 | Smith Nicholas Conrad | officer | Option exercise | 24,056 | $2.35 | $57K |
| 2026-09-30 | Smith Nicholas Conrad | officer | Sale | 23,170 | $25.78 | $597K |
| 2026-09-30 | Smith Nicholas Conrad | officer | Sale | 886 | $26.87 | $24K |
| 2026-09-29 | Smith Nicholas Conrad | officer | Option exercise | 56,455 | $2.35 | $133K |
| 2026-09-29 | Smith Nicholas Conrad | officer | Option exercise | 54,375 | $2.35 | $128K |
| 2026-09-29 | Smith Nicholas Conrad | officer | Sale | 110,830 | $26.58 | $2.95M |
| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-07-27 | SCHEDULE 13G | BlackRock, Inc. | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-06-25 | SCHEDULE 13G | Fulcrum Therapeutics, Inc. FULC | — | — | view → |
| 2026-06-25 | SCHEDULE 13G | Fulcrum Therapeutics, Inc. FULC | — | — | view → |
| 2026-06-16 | SCHEDULE 13G | Eloxx Pharmaceuticals, Inc. ELOX | — | — | view → |
| 2025-05-19 | SCHEDULE | GALAPAGOS NV GLPGF | 11.84% | 7,803,202 | view → |
| 2025-03-17 | SCHEDULE | Zymeworks Inc. ZYME | 24.20% | 16,858,418 | view → |
| 2025-02-18 | SCHEDULE | Zymeworks Inc. ZYME | 22.80% | 15,720,161 | view → |
| 2025-01-13 | SCHEDULE | Zymeworks Inc. ZYME | 22.40% | 15,411,078 | view → |
| 2025-01-03 | SCHEDULE | PROTHENA CORP PUBLIC LTD CO PRTA | 21.50% | 11,584,280 | view → |
| 2024-10-08 | SC | GALAPAGOS NV GLPGF | — | — | view → |
| 2022-01-14 | SC | PROTHENA CORP PUBLIC LTD CO PRTA | — | — | view → |
| 2021-05-11 | SC | ANAPTYSBIO, INC ANABV | — | — | view → |
| 2021-04-13 | SC | ANAPTYSBIO, INC ANABV | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →